These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 3332140)
1. Evaluation of a monoclonal IgM antibody for purging of bone marrow for autologous transplantation. Zola H; Potter A; Neoh SH; Juttner CA; Haylock DN; Rice AM; Favaloro EJ; Kabral A; Bradstock KF Bone Marrow Transplant; 1987 Feb; 1(3):297-301. PubMed ID: 3332140 [TBL] [Abstract][Full Text] [Related]
2. Low antigen density leukemia cells: selection and comparative resistance to antibody-mediated marrow purging. Janssen WE; Lee C; Gross S; Gee AP Exp Hematol; 1989 Mar; 17(3):252-7. PubMed ID: 2917623 [TBL] [Abstract][Full Text] [Related]
3. CD9 is an unreliable antibody for bone marrow purging. Fort JA; Rios AM; Gross S; Janssen WE Prog Clin Biol Res; 1990; 333():185-9. PubMed ID: 2408060 [TBL] [Abstract][Full Text] [Related]
4. Immunomagnetic microsphere mediated purging of cALLa positive leukemic cells from bone marrow for autologous reinfusion. Janssen WE; Lee C; Johnson KS; Spencer C; Rios AM; Graham-Pole JR; Gross S Prog Clin Biol Res; 1990; 333():285-92. PubMed ID: 2137931 [TBL] [Abstract][Full Text] [Related]
5. Immunomagnetic bone marrow purging of common acute lymphoblastic leukemia cells: suitability of BioMag particles. Trickett AE; Ford DJ; Lam-Po-Tang PR; Vowels MR Bone Marrow Transplant; 1991 Mar; 7(3):199-203. PubMed ID: 2059757 [TBL] [Abstract][Full Text] [Related]
6. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55. Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266 [TBL] [Abstract][Full Text] [Related]
7. Vim-2, candidate monoclonal antibody for purging autologous marrow grafts in acute myeloblastic leukaemia. Delwel R; Bot F; Knapp W; Löwenberg B Bone Marrow Transplant; 1987 Aug; 2(2):149-54. PubMed ID: 3332163 [TBL] [Abstract][Full Text] [Related]
8. Expression of differentiation-associated antigens and adhesion molecules on CD34-positive cells harvested from peripheral blood and bone marrow. Inaba T; Shimazaki C; Tatsumi T; Yamagata N; Hirata T; Goto H; Fujita N; Nakagawa M Prog Clin Biol Res; 1994; 389():331-7. PubMed ID: 7535439 [No Abstract] [Full Text] [Related]
9. In vitro purging of bone marrow for autologous marrow transplantation in acute myelogenous leukemia using myeloid-specific monoclonal antibodies. Ball ED Bone Marrow Transplant; 1988 Sep; 3(5):387-92. PubMed ID: 3056546 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibody 55 (CD10) and complement used for purging autologous bone marrow in common acute lymphoblastic leukemia. Bai Y; Piao XH; Luo QL; Mao BZ Chin Med J (Engl); 1990 May; 103(5):385-90. PubMed ID: 2118055 [TBL] [Abstract][Full Text] [Related]
11. [Monoclonal antibody and purging]. Ueda R; Morishima Y Gan No Rinsho; 1989 May; Spec No():294-302. PubMed ID: 2601016 [No Abstract] [Full Text] [Related]
12. CD5 antigen-positive B lymphocytes in human B cell ontogeny during fetal development and after autologous bone marrow transplantation. Waddick KG; Uckun FM Exp Hematol; 1993 Jun; 21(6):791-8. PubMed ID: 7684704 [TBL] [Abstract][Full Text] [Related]
13. Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging. Canals C; Picón M; Sanchez T; Torrico C; Amill B; Tugues D; Sierra J; Grañena A; Badell I; Brunet S Prog Clin Biol Res; 1994; 389():125-32. PubMed ID: 7700894 [No Abstract] [Full Text] [Related]
14. The effect of DNAse on the detection of residual malignant cells by polymerase chain reaction after immunologic purging of autologous bone marrow grafts. Vervoordeldonk SF; Merle PA; Steenbergen EJ; van Leeuwen EF; von dem Borne AE; Slaper-Cortenbach IC Prog Clin Biol Res; 1994; 389():601-9. PubMed ID: 7700926 [No Abstract] [Full Text] [Related]
15. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody. Ball ED; Graziano RF; Fanger MW J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189 [TBL] [Abstract][Full Text] [Related]
16. Use of CD33 monoclonal antibodies in bone marrow transplantation for acute myeloid leukemia. Robertson MJ; Roy DC; Stone RM; Ritz J Prog Clin Biol Res; 1994; 389():47-63. PubMed ID: 7700916 [No Abstract] [Full Text] [Related]
17. Natural killer cell regeneration after transplantation with mafosfamide purged autologous bone marrow. Almici C; Manoni L; Carlo-Stella C; Garau D; Cottafavi L; Rizzoli V Bone Marrow Transplant; 1995 Jul; 16(1):95-101. PubMed ID: 7581136 [TBL] [Abstract][Full Text] [Related]
18. Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement. Grañena A; Castellsagué X; Badell I; Ferra C; Ortega J; Brunet S; Puntí C; Sureda A; Picón M; Valls A; Rutllant M; García J Bone Marrow Transplant; 1999 Sep; 24(6):621-7. PubMed ID: 10490727 [TBL] [Abstract][Full Text] [Related]
19. [In vitro treatment of human bone marrow in the elimination of tumor cells: initial experiences with cytotoxic monoclonal anti-T-cell antibody LAU-A1]. Brun del Re GP; Baumgartner C; Stern AC; Hirt A; Carrel S Schweiz Med Wochenschr; 1984 Oct; 114(40):1379-82. PubMed ID: 6333721 [TBL] [Abstract][Full Text] [Related]
20. Elimination of clonogenic tumor cells from human bone marrow using a combination of monoclonal antibody:ricin A chain conjugates. Bregni M; De Fabritiis P; Raso V; Greenberger J; Lipton J; Nadler L; Rothstein L; Ritz J; Bast RC Cancer Res; 1986 Mar; 46(3):1208-13. PubMed ID: 3510720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]